12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks showed significant movement in Thursday's after-market session. CVRx, SeaStar Medical Holding, Eargo, DexCom, China SXT Pharmaceuticals, and Alaunos Therapeutics saw gains, while TransCode Therapeutics, PTC Therapeutics, ContraFect, Bio-Rad Laboratories, Day One Biopharmaceutical, and Processa Pharma experienced losses. Q3 earnings reports were released for CVRx, DexCom, PTC Therapeutics, and Bio-Rad Laboratories.
October 26, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVRx stock moved upwards by 48.0% to $19.0 after Q3 earnings report.
The significant increase in CVRx's stock price is likely due to the release of their Q3 earnings report, which investors may have perceived positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
DexCom stock moved upwards by 14.69% to $93.01 after Q3 earnings report.
The increase in DexCom's stock price is likely due to the release of their Q3 earnings report, which may have been received positively by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bio-Rad Laboratories shares decreased by 10.82% to $260.0 after Q3 earnings report.
The decrease in Bio-Rad Laboratories' stock price is likely due to the release of their Q3 earnings report, which investors may have perceived negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
PTC Therapeutics stock declined by 15.75% to $20.18 after Q3 earnings report.
The decline in PTC Therapeutics' stock price is likely due to the release of their Q3 earnings report, which may have been received negatively by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100